Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.69 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.69 |
| ▸ | HRH1 | P35367 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31312311 | 0.91 | CYP2C9 (0.82) | CYP2C9ADRA1AHRH1 | |
| SCHEMBL787600 | 0.91 | CYP2C9 (0.83) | CYP2C9ADRA1AHRH1 | |
| SCHEMBL31350040 | 0.91 | CYP2C9 (0.83) | CYP2C9ADRA1AHRH1 | |
| SCHEMBL31312166 | 0.89 | CYP2C9 (0.61) | CYP2C9ADRA1AHRH1 | |
| SCHEMBL31312098 | 0.88 | CYP2C9 (0.69) | CYP2C9ADRA1AHRH1 | |
| SCHEMBL31312010 | 0.87 | CYP2C9 (0.70) | CYP2C9ADRA1AHRH1 | |
| SCHEMBL31312054 | 0.87 | CYP2C9 (0.63) | CYP2C9ADRA1AHRH1 | |
| SCHEMBL31312115 | 0.87 | CYP2C9 (0.61) | CYP2C9ADRA1AHRH1 | |
| SCHEMBL31312120 | 0.86 | CYP2C9 (0.65) | CYP2C9ADRA1AHRH1 | |
| SCHEMBL31409549 | 0.85 | CYP2C9 (0.62) | CYP2C9ADRA1AHRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024263563-A1 | METABOTROPIC GLUTAMATE SUBTYPE-2 AND -3 RECEPTOR POSITIVE ALLOSTERIC MODULATORS AND USES THEREOF | Sanford Burnham Prebys Medical Discovery Institute (US) | 2024-12-26 | — | — | WO | disclosed |